1. Home
  2. HUBC vs NKGN Comparison

HUBC vs NKGN Comparison

Compare HUBC & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • NKGN
  • Stock Information
  • Founded
  • HUBC 2017
  • NKGN 2017
  • Country
  • HUBC Israel
  • NKGN United States
  • Employees
  • HUBC N/A
  • NKGN N/A
  • Industry
  • HUBC
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HUBC
  • NKGN Health Care
  • Exchange
  • HUBC Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • HUBC 16.0M
  • NKGN 13.5M
  • IPO Year
  • HUBC N/A
  • NKGN N/A
  • Fundamental
  • Price
  • HUBC $0.57
  • NKGN $0.39
  • Analyst Decision
  • HUBC
  • NKGN
  • Analyst Count
  • HUBC 0
  • NKGN 0
  • Target Price
  • HUBC N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • HUBC 719.2K
  • NKGN 367.2K
  • Earning Date
  • HUBC 10-08-2024
  • NKGN 09-12-2024
  • Dividend Yield
  • HUBC N/A
  • NKGN N/A
  • EPS Growth
  • HUBC N/A
  • NKGN N/A
  • EPS
  • HUBC N/A
  • NKGN N/A
  • Revenue
  • HUBC $42,657,000.00
  • NKGN N/A
  • Revenue This Year
  • HUBC N/A
  • NKGN N/A
  • Revenue Next Year
  • HUBC N/A
  • NKGN N/A
  • P/E Ratio
  • HUBC N/A
  • NKGN N/A
  • Revenue Growth
  • HUBC N/A
  • NKGN N/A
  • 52 Week Low
  • HUBC $0.44
  • NKGN $0.36
  • 52 Week High
  • HUBC $9.40
  • NKGN $5.10
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 54.49
  • NKGN 29.25
  • Support Level
  • HUBC $0.56
  • NKGN $0.36
  • Resistance Level
  • HUBC $0.67
  • NKGN $0.40
  • Average True Range (ATR)
  • HUBC 0.06
  • NKGN 0.06
  • MACD
  • HUBC 0.02
  • NKGN 0.00
  • Stochastic Oscillator
  • HUBC 58.07
  • NKGN 6.47

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: